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ADP/ATPase in glomerular filtration barrier (abst) 361
ADPKD
congenital hepatic fibrosis 880
lifespan (abst) 1238
renal structure, hypertension 1177
symptomatic forms (abst) 1237
AN69 membrane, anaphylactoid reactions 982
ANCA titer in therapy of Wegener's granulomatosis
(abst) 364
ATPase
adrenergic regulation of (Na,K) 402
vacuolar proton pumps 649
Ablation, renal damage, hypertension 642
Acid
disorders of distal acidification 720
load removal, ketoacidosis in fasting 507
Acid-base
homeostasis, reclamation of filtered bicarbonate 584
regulation, single nephron studies 744
renal handling of citrate 728
status, collecting duct intercalated cells 668
Acidification
vacuolar proton pump 649
Acidosis
chronic respiratory, urinary Ca excretion 409
disorders of distal acidification 720
Acute glomerulonephritis, hyperkalemia 1159
Acute pyelonephritis (abst) 546
Acute renal failure
active cation transport in uremia 1061
chromate induced (abst) 1236




reactive oxygen metabolites 1125
regional citrate anticoagulation in CAVHD 976
somatosensory evoked potentials 1085
survival of renal allografts (abst) 360
uninephrectomy (abst) 359
Wegener's granulomatosis (abst) 548
Acute uric acid nephropathy (abst) 367
Adenosine
ecto 5'-nucleotidase is main source of (abst) 366
Adrenoreceptor, angiotensin II 30:S-84
Afferent arterioles, renin release 426
Albumin, edema formation in diabetic nephropathy.... 1187
Albuminuria
perindopril vs. triple therapy (abst) 552
steroid-responsive SIRS production 151
Albuterol, insulin treatment of hyperkalemia 869
Aldosterone
action and hypokalemia 812
adjustment to K loading in humans 942
felodipine (abst) 1232
Alkaline phosphatase
in dialysis (abst) 362
intestinal, mercury exposed and analgesic abusers
(abst) 363
Alkalosis, respiratory, PTH 258
Allograft
live donor (abst) 560
survival and ARF (abst) 360




bone matrix inductive properties 1141
calcium acetate or calcium citrate, intestinal
absorption 937
urine net charge an index of urinary (abst) 367
Amino acids
plasma and muscle free, HD 108
taurine transport in epithelial cell lines 219
Aminophylline infusion and glucose in uremia 1146
Amyloid deposit imaging in dialysis 1169
Analgesic nephropathy rates in Switzerland (abst) 369
Anaphylactoid reactions, AN69 membrane 982
Anemia
cutaneous blood flow, rHuEPO 919
i.v. and s.c. administration of rHuEPO (abst) 372
rHuEPO improves brain function 480
Angiotensin
biology of renin-, system S-18
genetic hypertension 30:S-92
receptor, signaling mechanisms 30:S-43
renal vascular hypertension 30:S-97
Angiotensin I




arteriolar renin, juxtamedullary nephron 30: S-60
biology of renin-angiotensin system 30:S-l8
calcium-activated Cl conductance 30:S-48
cortical, juxtamedullary arterioles, norepinephrine. 30:S-55
distal part of afferent arteriole, morphology 30:S-lO
glomerular growth 1068
hemodynamics and congestive heart failure 30:S-123
hemodynamics, tubular reabsorption 30:S-69
influences phospholipase A2 30:S-43
inhibits ANP (abst) 551
intracellular Ca and electrical function 30:S-51
intrarenal effects with ANF 30:S-87
lisinopril (abst) 1230
pressor agents on TGF 30:S-77
receptor antagonist, DuP 753 473
receptor expression (abst) 554
receptor regulation in anti-GBM nephritis 518
release from juxtaglomerular cells 30:S-33
renal ablation 862
renal artery narrowing, BP, GFR 30:S-109
renal metabolism 30:S-24
renin release from juxtaglomerular apparatus 30:S-38
saralasin, CEI, hemodynamics 30:S-74
structure of glomerular mesangium 30:S-2
1271
1272 Subject Index: Vol. 38
thromboxane, BP 30:S-81
Angiotensin converting enzyme inhibition
anemia, in transplants (abst) 561
antiproteinuric effect (abst) 1230
diabetic nephropathy, salt (abst) 553
Angiotensin converting enzyme inhibitor
anaphylactoid reactions during HD 982
Benazepril 101
glomerular growth 1068
human growth hormone and GFR (abst) 368
progression of CRF 30:S-118
Angiotensinase A, renal ablation 862
Anti-GBM disease
effects of deoxyspergualin (abst) 556
granulocytes in heterologous 86
lymph drainage (abst) 556
macrophages and crescent formation (abst) 555
procoagulant activity (abst) 557
Anti-neutrophil cytoplasmic autoantibody
associated renal disease 998
Antibodies
anti-lung induced Goodpasture's syndrome (abst) 557
anti-neutrophil cytoplasmic, IgG4 subclass (abst) 364
associated renal disease, ANCA 998
hepatitis B vaccination, IL-2 receptors, CRF 1164
hepatitis C assay 320
HTLV-1 in Aboriginals with renal failure (abst) 548
immune complex formation and clearance 1075
T and B cell, HLA match (abst) 1234
Antigen
class 11, ICAM-1 function 417
heat shock protein, 90-kDa 830
HLA, dialysis membranes and B2m expression 962
isolation of GBM (abst) 1232
nitrite in nephrotoxicity 1056
presenting cells, mesangial accessory functions 1039
rHuEPO and sensitivity to HLA 12
Antioxidants, ischemic injury 1109
Apoptosis, atrophy, renal papillary necrosis (abst) 554
Arginine vasopressin
gene expression in heart failure 818
interaction with Ang II on Ca2 47
Arteriole
afl'erent, renin-secreting segment 30:S-65
distal part, morphology 30:S-l0
Arteriovenous fistulae, predictors of outcome (abst) .... 559




blood pressure control (abst) 359
endopeptidase inhibition 67
in acute nephritic and nephrotic syndromes 512
inhibits hypertonic saline-mediated hemodynamic
decreases 227
metabolism of Ang I and Ang II 30:S-24
radiocontrast induced nephropathy 1101
syndrome of deficiency (abst) 365
Atrial natriuretic peptide
blunts hypoxemia-induced decrease in GFR (abst). . . . 365
cyclic GMP (abst) 1231
inhibition by Ang II (abst) 55!
receptors during salt loading 73
renin essential hypertension 30:S-l07
role of dopamine 1133
vasodilator theophylline (abst) 361
Auto-immune glomerulonephritis
murine host-vs.-graft reaction (abst) 1230
Autocrine growth factor, interleukin-6 249
Autoimmunity in IgAN, gene 332
Autoradiography of adrenergic receptors 39
Autoregulation
distal portion of afferent arteriole, morphology .. . 30:S-10
glomerular blood flow 769
renal circulation 571
Benazepril, ACE inhibitor 101
1 iBeta-hydroxysteroid dehydrogenase, Na transport.... 673
Beta 2-microglobulin
dialysis membranes 962
imaging of amyloid deposits 1169
Beta amino acid transporter, taurine 219
Beta blockade, propranolol in respiratory alkalosis 258
Bicarbonate
absorption, model of proximal tubule 605
collecting duct intercalated cells 668
disorders of distal acidification 720
reclamation of filtered 584
Binding sites, bradykinin (abst) 1237
Biocompatability in hemodialysis membranes 487
Biopsy
immunoregulatory factors in IgAN 1216
real time, ultrasonic guidance, semiautoniated device . 347
renal (Nephrology Forum) 529
renal, in elderly (abst) 1236
ten year retrospective analysis (abst) 546
zero-hour, morphologic findings (abst) 372
Blood
coagulation, thrombin 956
conjugated estrogens and platelet function in CRF . . . 1181
cutaneous flow, coagulability, rHuEPO 919
fistula dysfunction, high-efficiency HD 337
flow, Ang II receptors in anti-GBM nephritis 518
levels with cyclosporine (abst) 363
red cell trapping, ischemic renal failure 432
renal corticomedullary portal systems (abst) 550
renin release from juxtaglomerular apparatus 30:S-38
vessels, renin release 612
volume monitoring during HD 342
zeranol shortens bleeding time in uremia 96
Blood flow
congestive heart failure, Ang II 30:S-123
glomerular 769juxtamedullary, NE and Ang 11 effect 30:S-55
mesangial cell accessory functions 1039
serotonin blocking agent, hemodynamics 823
Blood pressure
angiotensin II and ANF 30:S-87
angiotensinogenases in vasculature 30:S-28
biology of renin-angiotensin system 30:S-l8
control and ANF (abst) 359
distal part of afferent arteriole, morphology 30:S-lO
high-efficiency L-lactate HD 896
immunoregulation in IgAN 1216
management in home HD (abst) 559
renal structure, hypertension in ADPKD 1177
renal vascular hypertension, angiotensin 30:S-97
thromboxane and Ang II 30:S-8l
Bone
analysis of plasma vitamin D metabolites 29:S-28
Subject Index: Vol. 38 1273
crystallization inhibitors, mineral regulation 625
disease 193
effects of 1 ,25(OH)2D3 therapy 29:S-48
matrix inductive properties (Al) 1141
mineral density in transplantation (abst) 371
oral and parenteral calcitriol in osteodystrophy ... 29:S-54
parathyroidectomy in CRF, calcitriol 29:S-62
renal control of extracellular Ca 700
vitamin D 29:S-l7
Bradykinin, binding (abst) 1237
Brain function, rHuEPO therapy improves 480
Brush border membrane
ANP inhibits Na-H antiport, dopamine 1133
vesicles studied by cytometry 5
CAPD
campylobacter peritonitis (abst) 559
cellular cytokine production 129
glucose resorption, lymphatic absorption (abst) 362
immunoadsorption and transplantation 350
loss of ultrafiltration capacity, peritoneal transport . . . . 495
variation in dialysate volume 465
CAVHD, regional citrate anticoagulation 976
CR1 (CD)35 mRNA in podocytes 289
Calcification
bone matrix inductive properties, Al 1141




oral and parenteral, osteodystrophy 29:S-54
parathyroidectomy in CRF 29:S-62
Calcium
activated Cl conductance of mesangial cells 30:S-48
active analogues of vitamin D 29:S-22
arginine vasopressin and Ang II interaction on 47
calmodulin, protein kinase II 63
channel blockade, hypertension (abst) 553
cytosolic free, mesangial cells 1199
entry blockers, influx (abst) 1232
excretion, chronic respiratory acidosis 409
intracellular, electral function and Ang II 30: s-SI
ionized, dialysis membranes, iPTH assays in HD 308
parathyroid-calcitriol axis in CRF 29:S-41
renal control of extracellular 700
tracer kinetics of vitamin D3 857
Calcium acetate, intestinal Al absorption 937
Calcium citrate, acetate effect on Al absorption 937
Captopril
compared with enalapril (abst) 546
converting enzyme inhibition, GFR, proteinuria 590
renal artery stenosis (abst) 544
Carcinoma and IGAN (abst) 1237
Carnitine
concentrations, lipid effects of L-carnitine in HD 904
Catheter
diagnosis of pyelonephritis 835
predictive value of ureteric, infection 546
prophylactic filling with heparin or urokinase (abst).. . 370
right atrial (abst) 558
Cation in transport, uremia 1061
Cell
class II antigens and ICAM-l function 417
epithelial polarity
glomerular mesangium, structure 30:S-2
growth, TGF-131 and TGF-/32 1095
oxygen molecule-mediated injury 785
volume regulation, TALH 1019
Cellular cytokine production, renal replacement 129
Children
steroid-sensitive nephrotic syndrome 145
twenty year's experience in transplantation (abst) .. . . 561
Chimeric mammalian kidney 991
Chloride
conductance of mesangial cells, Ca activated 30:S-48
transport across the IMCD 654
Cholangiocarcinoma model of jaundice 948
Chromate induced ARF (abst) 1236
Chronic cardiac failure, AVP gene expression 818
Chronic renal failure
branched-chain ketoacids 595
cation transport in uremia 1061
children, recombinant growth hormone (abst) 548
conjugated estrogens 1181
converting enzyme inhibition 590
dysfunction of NADPH-oxidase (abst) 361
estrogens, platelet function and prostacyclin 1181
extrarenal production of calcitriol 29:S-36
final height in children (abst) 369
hepatitis B vaccination and IL-2 receptors 1164
in Aboriginal population (abst) 545
L-carnitine in HD, concentrations and lipids 904
measurement of renal function 167
parathyroid-calcitriol axis 29:S-41
parathyroidectomy 29:S-62
plasma osmolality causes hyperkalemia 301
progression and ACEI 30:S-l 18
pyrimidine metabolism (abst) 362
renal biopsy 529
tracer kinetics of vitamin D3 857
tubulointerstitial nephritis 736
vitamin D therapy effect on bone 29:S-48
Chronic respiratory acidosis 409
Circadian rhythms of C1 and Ccr (abst) 1231
Cisplatin, late renal sequelae (abst) 365
Citrate
regional anticoagulation, CAVHD 976
renal handling 728
Clearance
inulin and creatinine, circadian rhythms (abst) 1231
obstructive jaundice 948
renal function reserve (abst) 1231
tubular immune complex formation 1075
Clonidine inhibits fluid absorption in PCT 80




sodium and potassium transport 679
Contractile filaments in glomerular mesangium 30:S-2
Convective transport 19
Converting enzyme inhibition
renin-angiotensin system, transplantation 30:S-114
saralasin, Ang II, hemodynamics 30:S-74
Cortical collecting duct
mechanism of PGE2 and vasopressin interactions 618
mineralocorticoids during hypokalemia 812
sodium and potassium transport 679
Corticomedullary portal systems (abst) 550
Corticosteroid receptors, mineralocorticoid specificity... 673
1274 Subject Index: Vol. 38
Countercurrent system 695
Creatinine
measuring renal function in CRF 167
renal structure, hypertension in ADPKD 1177
Crescentic glomerulonephritis
IL-2R mononuclear cell (abst) 556
interstitial IL-2R+ mononuclear cells (abst) 554
Crescents, ANCA associated renal disease 998
cyclic AMP, insulin secretion in uremia 1146
cyclic GMP, ontogeny by ANP (abst) 1231
Crystal inhibitors, mineral regulation 625
Cyclosporin A
cytokine production, survival, IL-2R (abst) 560
glomerular hemostatic changes (abst) 367
host defence in infection (abst) 556
ketokonazole interaction, glucose intolerance (abst)... 371
Cyclosporine
blood levels with oral or capsules (abst) 363
cadaver kidney transplantation (abst) 560
calcium channel blocker (abst) 553
immediate hemodynamic effects (abst) 1233
Cyst, renal structure, hypertension in ADPKD 1177
Cysteine
proteinases, GBM degradation 395
Cytokines
in nephrotic syndrome (abst) 557
Cytometry of BBM 5
Cytoskeleton
mesangial cell contraction by TNF 795
DMSA scintigraphy, urinary tract infection (abst) 544
Deoxyspergualin
cytotoxic T lymphocytes (abst) 557
Desferrioxamine
enhances response to rHuEPO (abst) 545
Desoxyspergualin, anti-GBM nephritis (abst) 556
Diabetes
familial, sodium-lithium countertransport (abst) 361
low sodium diet, hyperfiltration (abst) 550
Diabetes mellitus
determinants of renal damage, hypertension 642
glomerular permeability to macromolecules 384
in Aboriginal population (abst) 545
increased mortality post-transplantation (abst) 363
lithium marker (abst) 551
proximal tubule cell Na transport (abst) 548
Diabetic nephropathy
edema 1187
hyperlipidemia and hypertension (abst) 553
salt, ACE inhibition (abst) 553
Dialysate
calcium acetate, citrate, Al absorption 937
L-lactate in high-efficiency HD 896
variation in volume in CAPD 465
Dialysis
alkaline phosphatase (abst) 362
fistula dysfunction, high-efficiency 337
membranes, J32-m expression 962
peritonitis-induced drop-outs (abst) 362
recovery of renal function (abst) 373
related AB-amyloid deposits 1169
transplantation in Aboriginal population (abst) 545
Dialysis membranes
iPTH values 308
prophylactic filling with heparin or urokinase (abst). . . 370
Dialyzer
anaphylactoid reactions, AN69 membrane, ACE! 982
132-microglobulin levels (abst) 558
blood and dialysis membranes, protein catabolism.... 487
blood protein monitoring during HD 342
induction of IL-I during HD 1089
membranes, 2m expression 962
reprocessing with Renalin (abst) 558
Diet
acid-base regulation 744
adjustment to K loading in humans 942
antioxidants and ischemic injury 1109
branched-chain ketoacids 595
fatty acids in transplantation (abst) 1233
fish oil supplements 315
protein effect on renin-angiotensin system 240
removal of inorganic acid load with fasting 507
renal, hormonal responses to animal & veg proteins .. 136
Distal acidification, disorders 720
Distal nephron
lithium treatment, kallikrein excretion 124
Distal segment of afferent arteriole 30:S-10
Diuretic, renal effects of 632
Dopamine
ANP inhibits antiport in BBM 1133
urodilation, ischemic renal failure (abst) 365
Drug induced ARF (abst) 1237
DuP 753, nonpeptide angiotensin II receptor antagonist . 473
Ecto 5'-nucleotidase and renal adenosine (abst) 366
Edema
formation in diabetic nephropathy 1187





regulation of renin release 612
Electrolytes
macula densa-mediated hemodynamics 1206
nI measurement by ion specific microelectrodes 525
End-stage renal disease
analgesic nephropathy (abst) 369
cellular cytokine production 129
gene mapping in Alport's syndrome 925
life span of ADPKD (abst) 1238




determinants of renal damage, hypertension 642
final height in children with (abst) 369
growth velocity in children, rHuEPO (abst) 547
immunoadsorption in sensitized transplant recipient... 350
low dose rHuEPO therapy (abst) 544
permselectivity in glomerulosclerosis 384
radioimmunoassay for rHuEPO 969
soft tissue calcification in children with 931
vascular heparan sulphate (abst) 555
Endopeptidase inhibition and ANF 67
Endoproteinase, cysteine in GBM 395
Endothelial cell
molecules, GBM (abst) 554
oxygen molecule-mediated injury 785
Subject Index: Vol. 38 1275
Endothelin
hemodynamics (abst) 550
sodium excretion (abst) 549
stimulates PDGF secretion 1193
vasoconstrictor (abst) 550
Endotoxin
induction of IL-I during HD 1089
reactive oxygen metabolites in ARF 1125
Entactin, possible auto-antigen 263
Enzyme
angiotensinogenases in vasculature 30: S-28
antioxidant role in oxidant injury 282
calcium-calmodulin protein kinase H 63
kallikrein excretion rate, lithium 124
metabolism on Ang I and Ang II 30:S-24
secretion of renin, IRR in vivo 440
vacuolar proton pump 649
Epithelial cell
class II antigens, ICAM-l 417
injury, Ca and protein kinase C 803
membrane polarity organization in
taurine transport in renal cell lines 219
three-D morphology of segmental glomerulosclerosis.. 851
Erythremia post-transplantation (abst) 1233
Erythrocyte
trapping, ischemic renal failure 432
Erythropoietin
application in HD (abst) 370
improves brain function 480
Estrogen
conjugated, platelet function and prostacyclin 1181
receptor blocking, zeranol in uremia 96
Exchanger, Na/Ca2 in mesangial cells 1199
Excretion
adjustment to K loading in humans 942
calcium, chronic respiratory acidosis 409
kallikrein, regulation by glucocorticoids 212
Exercise
tolerance, L-carnitine 912
white collar rhabdomyolysis 709
Exocytosis, renin release 30:S-38
Extracellular matrix
formation by mesangial cells (abst) 360
Fasting, ketoacidosis 507
Fatty acids
L-carnitine, lipids in HD 904
clinical and biochemical effects of L-carnitine 912
Felodipine, aldosterone (abst) 1232
Fibrinolytic system, thrombin 956
Fibrosis
congenital hepatic, in ADPKD 880
hepatic, PKD (abst) 547
Fish oil, during rejection (abst) 1232
Fistula
dysfunction, high-efficiency HD 337
Flow cytometry to study BBMV 5
Fluorescence
activated cell sorting, proximal tubules (abst) 359
flow cytometry 5
Focal glomerulosclerosis
hypertrophy in MCD predicts progression to 115
Fosinopnl in hypertension 873
Free radical
probucol effect in ureteral obstruction 843
Furosemide
renin essential hypertension, ANP 30:S-107
G protein
mesangial cell growth, retinoic acid (abst) 551
Gangrene with hyperparathyroidism in HD (abst) 370
Gene
chimeric mammalian kidney 991
expression, vitamin D system 29:S-2
hepatic fibrosis in ADPKD 880
immunoglobulin heavy chain switch region, IgAN.... 332
mapping of Alport families 925
Gentamicin
toxicity in S3 segment, ischemia 459
Glomerular basement membrane
characteristics of Na/Ca2 exchanger 1199
degradation by system proteinases 395
endothelial cell molecules (abst) 554
entactin, Goodpasture anti-GBM nephntis 263
isolation of mouse (abst) 1232
mesangial matrix ultrastructure 1211
structure of glomerular mesangium 30:S-2
Glomerular filtration rate
acid-base regulation 744
ADP/ATPase in barrier (abst) 361
adrenergic influences, Ang H 30:S-84
adrenergic receptors 39
blood flow 769
blood flow, artery narrowing, Ang II 30:S-109
calcium-activated Cl conductance 30:S-48
captopril 590
chimeric mammalian kidney 991
congestive heart failure, Ang II 30:S-123
effects of ANF 227
eicosanoids and mesangial cell injury 273
endothelin, PDGF secretion 1193
extracellular space in macula densa 30:S-l6
fosinopril 873
hemostatic changes in CsA toxicity (abst) 367
human growth hormone (abst) 368
in Milan hypertensive rats, TGF 30:S-102
ischemic renal failure, erythrocyte trapping 432
kallikrein regulation by glucocorticoids 212
measurement of renal function 167
plasma oncotic pressure (abst) 551
radiocontrast induced nephropathy 1101
renal function reserve (abst) 1231
serotonin blocking agent 823
Glomerulonephritis
ANCA associated renal disease 998
ANF 512
anti-GBM, Ang II receptor regulation 518
anti-GBM, role of granulocytes 86
hyperkalemia, transient hyporeninemic
hypoaldosteronism 1159
immunoglobulin switch region RFLPs 332
impairment of renal function with IgG (abst) 369
in Australian city, 10 year study (abst) 546




altered glomerular permeability to macromolecules. . . . 384
angiogenic action of Ang II in glomerular growth.... 1068
thromboxane A2 role in progressive kidney disease.... 447
1276 Subject Index: Vol. 38
Glomerulus




induced insulin secretion in uremia 1146
lymphatic absorption in children on CAPD (abst) 362
Glycoprotein
CR1 (CD 35) mRNA in podocytes 289
renin content after renin secretion 440
anti-GBM nephntis, entactin 263
Goodpasture's syndrome
anti-lung antibody induces (abst) 557
anti-GBM nephritis, entactin 263
Graft-vs.-host disease
dipeptidyl peptidase IV and laminin (abst) 1232
Growth
angiogenic action of Ang H on glomerular 1068
Growth factor$- and /-2 in glomeruli 1095
interleukin-6 in mesangial cells 249
H-K-ATPase
immunoreactivity in CCD, OMCD 985
HLA
antibodies, immunoadsorption and transplantation.... 350
identical siblings, acute TIN (abst) 369
extended haplotypes, childhood steroid-sensitive NS.. 145
match, T and B cell antibodies (abst) 1234
sentization and rHuEPO 12
HSP 90 localization 830
Heart failure
angiotensin H, hemodynamics 30:S-l23
arginine vasopressin gene expression 818
management of refractory edema (abst) 546
radiocontrast induced nephropathy 1101
Heat shock protein, 90-kDa 839
Hematuria
immunoregulation in IgAN 1216
renal biopsy 529
Hemodialysis
activity of SLE (abst) 1234
albuteral and insulin treatment of hyperkalemia 869
amyloid deposit imaging with l3lB2m 1169
anaphylactoid reactions, ACE! 982
/-2 microglobulin levels (abst) 558
biocompatability 487
blood protein monitor 342
bone disease 193
cellular cytokine production 129
cutaneous blood flow, rHuEPO 919
cutaneous gangrene (abst) 370
erythropoietin (abst) 370
hepatitis C (abst) 558
hepatitis C infection 320
high efficiency, fistula dysfunction 337
home, BP management (abst) 559
i.v. and s.c. administration of rHuEPO (abst) 372
iPTH values during 308
immunoadsorption in sensitized transplant recipient... 350
interleukin-1 induction 1089
L-carnitine; biochemical effects 912
lipid effects and carnitine in L-carnitine HD 904
membranes, f-m expression 962
plasma and muscle free amino acids 108
plasma exchange with rotating filter 160
predictors of arteriovenous fistulae (abst) 559
prophylactic filling of catheters with heparin (abst) ... 370
quality of life with rHuEPO (abst) 548
rHuEPO improves brain function 480
recovery of renal function (abst) 372
renal biopsy 529
sterile infusate, pre-dilution hemofiltration (abst) 559
Hemodynamics
adrenergic influences, Ang II 30:S-84
ANF inhibits hypertonic saline-mediated decreases
in 227
angiotensin II and heart failure 30:S-123
biology of renin-angiotensin system 30:S-18
calcium-activated Cl conductance 30:S-48
contraction of mesangial cells by TNF 795
endothelin (abst) 550
glomerular growth of kidneys, Ang II 1068
immediate effects of CsA (abst) 1233
in Milan hypertensive rats, TGF 30:S-102
ingestion of animal, vegetable protein 136
macula densa-mediated glomerular 1206
n-3 fatty acids and PGE metabolism 315
new ACE inhibitor, Benazepril 101
obstructive jaundice 948
of L-lactate high efficiency HD 896
physiologic adaptations of TGF 577
renal ablation, angiotensinase A 862
renal vascular hypertension, angiotensin 30:S-97
renin-angiotensin system, transplantation 30:S-l14
renin-secreting segment of afferent arteriole 30:S-65
saralasin, Ang H, CE! 30:S-74
serotonin blocking agent 823
thromboxane, Ang II and BP 30:S-8l
tubular reabsorption, Ang II 30:S-69
Hemofiltration
intensive care ARF unit (abst) 559
pre-dilution, sterile infusate (abst) 559
Hemoglobin, response to rHuEPO (abst) 545
Hemorrhage, regional citrate in CAVHD 976
Henle's loop, descending limb of 687
Heparin
antiproteinuric effects (abst) 1230
low molecular weight in HF (abst) 370
sulfate, monoclonal antibody (abst) 1229
vascular sulphate release in ESRF (abst) 555
Hepatitis B_vaccination in !L-2 expression in CRF . . . . 1164
Hepatitis C
hemodialysis (abst) 558
infection in hemodialysis units 320
High efficiency hemodialysis, L-lactate 896
Homeostasis
disorders of distal acidification 720
renal effects of diuretics 632
tubuloglomerular feedback system 577
Hormone
active analogues of vitamin D 29:S-22
ANF in acute glomerulonephritis 512
atrial natriuretic factor and Ang H 30:S-87
AVP and Ang II interaction on Ca2 47
neutral endopeptidase inhibition, ANF 67
renin release by endothelium 612
sodium transport, IlB-hydroxysteroid
dehydrogenase 673
vitamin D therapy 29:S-2
Subject Index: Vol. 38 1277
Human recombinant erythropoietin
desferrioxamine (abst) 545
growth velocity in children (abst) 547
quality of life (abst) 548
stimulates platelets and thrombosis (abst) 559
Hydrogen ion secretion, bicarbonate 584
Hydronephrotic kidney, renin synthesis (abst) 549
Hypercalciuria
chronic respiratory acidosis, Ca excretion 409
Hyperfiltration
determinants of renal damage 642
fosinopril 873
low sodium diet (abst) 550
pachydermoperiostosis (abst) 1236
Hyperkalemia
albuterol and insulin treatment 869
plasma osmolality increase causes 301
transient hyporeninemic hypoaldosteronism 1159
Hypermetabolism, protein restriction (abst) 549
Hyperparathyroidism
calcitriol treatment in osteodystrophy 29:S-54
Hyperphosphatemia
calcium acetate and citrate on Al absorption 937
Hypertension
active renin in pregnancy-induced (abst) 553
adrenergic regulation of (Na ,K )-ATPase 402
angiogenic action of Ang II on glomerular growth ... 1068
angiotensin II, thromboxane, BP 30:S-81
angiotensinogenases in vasculature 30:S-28
antiproteinuric effect of ACE! (abst) 1230
captopril vs. enalapril (abst) 546
chronic tubulointerstitial nephritis 736
congenital hepatic fibrosis in ADPKD 880
determinants of renal damage 642
diabetic nephropathy, hyperlipidemia (abst) 553
edema formation in diabetic nephropathy 1197
fosinopril 873
genetic, Ang II 30:S-92
immunoregulation in IgAN 1216
kallikrein regulation by glucocorticoids 212
neutral endopeptidase and ANF 67
normotensive rat kidney model 28
preeclampsia prevention (abst) 544
pregnancy decidua (abst) 552
renal structure in ADPKD 1177
renal vascular, angiotensin 30: S-97
renal vascular, angiotensin 30:S-97
renin essential, ANP 30:S-107
syndrome of ANF deficiency in pre- (abst) 365
therapy with lisinopril (abst) 367
transplantation, renin-angiotensin system 30:S-114
tubuloglomerular feedback, Milan hypertensive
rats 30:S-102
verapamil, renal damage (abst) 366
Hypertrophy
angiotensinase A, renal ablation 862
in MCD predicts progression to FGS 115
Hypoalbuminemia, ANF 512
Hypoaldosteronism
transient hyporeninemic, hyperkalemia 1159
Hypokalemia
kaliuretic response to mineralocorticoids 812
Hypolipidemia, L-carnitine in HD 904
Hypotension
clinical and biochemical effects of L-carnitine 912
Hypoxemia
induced decrease of GFR prevented by ANP (abst).. . 365
induced renal insufficiency (abst) 366
Hypoxia, effects on cultured cells (abst) 555
ICAM- 1
class II antigens effect on tubular cells 417
IgA nephropathy
carcinoma (abst) 1237
immunoglobulin heavy chain switch region gene 332
immunoregulatory factors 1216
macrophage influx (abst) 1231
polymeric IgA and immune complex concentrations .. 323
IgG
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